900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Calcification	Ambiguous
Calcification of intervertebral cartilage AND/OR disc	Ambiguous
Calcification of intervertebral cartilage AND/OR disc of cervical region	Ambiguous
Calcification of intervertebral cartilage AND/OR disc of lumbar region	Ambiguous
Calcification of intervertebral cartilage AND/OR disc of thoracic region	Ambiguous
Calcification of lens	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcification of lung	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcification of tendon NOS	Limited component (foundation metadata concept)
Calcified	Ambiguous
Calcified structure	Ambiguous
Calcinosis	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcinosis following tissue necrosis/infarction	Ambiguous
Calcinosis, Raynaud's phenomenon, sclerodactyly, oesophageal dysfunction, telangiectasia syndrome	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcinosis, Raynaud's phenomenon, sclerodactyly, oesophageal dysfunction, telangiectasia syndrome	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcinosis: [universalis] or [other]	Ambiguous
Calcipotriene	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcipotriene 0.005% ointment	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcipotriene 0.005% solution	Ambiguous
Calcipotriene 0.005%/betamethasone 0.064% topical suspension	A component that is no longer current, useful, appropriate or acceptable.
Calcipotriene 50micrograms/mL scalp solution	Ambiguous
Calcipotriene hydrate 0.005% cream	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcipotriol hydrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment	A component that fails to comply with the current editorial guidance.
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment	A component that fails to comply with the current editorial guidance.
Calcitonin agent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcitonin and salcatonin	Ambiguous
Calcitonin measurement	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcitonin, salmon 100unit/mL injection solution 1mL vial	A component that is no longer current, useful, appropriate or acceptable.
Calcitonin, salmon 200iu/mL spray	A component that is no longer current, useful, appropriate or acceptable.
Calcitonin, salmon 200unt/mL injection	A component that is no longer current, useful, appropriate or acceptable.
Calcitonin, salmon 200unt/mL injection solution 2mL vial	A component that is no longer current, useful, appropriate or acceptable.
Calcitonin, salmon 400iu/2 mL injection	A component that fails to comply with the current editorial guidance.
Calcitonin, salmon 400iu/2 mL injection solution 2mL vial	A component that fails to comply with the current editorial guidance.
Calcitonin, salmon 50unit/mL injection solution 1mL vial	A component that fails to comply with the current editorial guidance.
Calcitriol 0.25mcg	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcitriol 0.25micrograms capsule	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcitriol 0.5mcg	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcitriol 0.5microgram capsule	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcitriol 1.0mcg/mL injection	Ambiguous
Calcitriol 1mcg/mL injection solution 1mL ampule	Ambiguous
Calcitriol 2mcg injection solution ampule	Ambiguous
Calcitriol 2mcg/mL solution	Ambiguous
Calcitriol 2micrograms/mL injection solution 1mL ampule	Ambiguous
Calcitriol 3micrograms/g ointment	Ambiguous
Calcium 667mg gel	A component that fails to comply with the current editorial guidance.
Calcium AND/OR calcium compound	A component that fails to comply with the current editorial guidance.
Calcium analyte	Erroneous component (foundation metadata concept)
Calcium and magnesium product	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium antacid	A component that is no longer current, useful, appropriate or acceptable.
Calcium calculus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium carbonate calculus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium carbonate compound powder	A component that fails to comply with the current editorial guidance.
Calcium carbonate pediatric compound mixture	A component that fails to comply with the current editorial guidance.
Calcium carbonate+cholecalciferol 1.25g/11micrograms/sachet granules	A component that is no longer current, useful, appropriate or acceptable.
Calcium channel blocker	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium channel blocker contraindicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium channel blocker contraindicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium channel blocker declined	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium channel blocker declined	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium channel blocker indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium channel blocker indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium channel blocker not indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium channel blocker not indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium chloride 0.5mmol/mL injection solution 10mL vial	A component that fails to comply with the current editorial guidance.
Calcium chloride 0.5mmol/mL injection solution 5mL vial	A component that fails to comply with the current editorial guidance.
Calcium chloride 10% injection solution 10mL prefilled syringe	A component that is no longer current, useful, appropriate or acceptable.
Calcium chloride 100mg/mL injection solution vial	A component that fails to comply with the current editorial guidance.
Calcium chloride 13.4% injection solution vial	A component that fails to comply with the current editorial guidance.
Calcium chloride 1mmol/mL injection solution 10mL vial	A component that fails to comply with the current editorial guidance.
Calcium chloride 1mmol/mL injection solution 5mL vial	A component that fails to comply with the current editorial guidance.
Calcium combination product	A component that fails to comply with the current editorial guidance.
Calcium compound 1000mg effervescent tablet	A component that fails to comply with the current editorial guidance.
Calcium compound 400mg effervescent tablet	A component that fails to comply with the current editorial guidance.
Calcium deficiency	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium deposits in bursa	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium deposits in tendon	Ambiguous
Calcium deposits in tendon AND/OR bursa	Ambiguous
Calcium diethylenetriaminepentaacetate[111In] 37MBq/mL injection	A component that fails to comply with the current editorial guidance.
Calcium glubionate + calcium lactobionate 1.09g/723mg/5mL syrup	Ambiguous
Calcium gluconate 10% injection solution ampule	A component that fails to comply with the current editorial guidance.
Calcium gluconate 100mg/mL injection solution ampule	A component that fails to comply with the current editorial guidance.
Calcium hydroxide dental cement	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium hydroxyapatite microsphere suspension in aqueous based carrier 0.3mL prefilled syringe	A component that is no longer current, useful, appropriate or acceptable.
Calcium hydroxyapatite microsphere suspension in aqueous based carrier 1.3mL prefilled syringe	A component that is no longer current, useful, appropriate or acceptable.
Calcium intake	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium intake	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium ionophore	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium oxalate and calcium phosphate calculus	Ambiguous
Calcium oxalate and hydroxyapatite calculus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium phosphate	Ambiguous
Calcium phosphate+colecalciferol 3100mg/20micrograms/sachet powder for oral suspension	A component that is no longer current, useful, appropriate or acceptable.
Calcium polystyrene sulfonate	A component that fails to comply with the current editorial guidance.
Calcium polystyrene sulfonate powder	A component that fails to comply with the current editorial guidance.
Calcium regulating agent allergy	A component that fails to comply with the current editorial guidance.
Calcium salt	Ambiguous
Calcium salt preparation	Ambiguous
Calcium salts	Ambiguous
Calcium sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium+ergocalciferol 400units tablet	A component that fails to comply with the current editorial guidance.
Calcium, serum, ionized measurement	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Calcium-channel blocker+angiotensin-converting enzyme inhibitor	Ambiguous

Start Previous Page 212 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)